中华眼底病杂志

中华眼底病杂志

阿托伐他汀对体外培养的大鼠骨髓间充质干细胞CXC趋化因子受体4表达及迁移能力的影响

查看全文

目的观察不同浓度阿托伐他汀(ATV)对体外培养的大鼠骨髓间充质干细胞(BMSC)中 CXC趋化因子受体4(CXCR4)表达及迁移能力的影响。方法分离培养鉴定大鼠BMSC。将第4~6代细胞分为对照组和ATV处理0.1 nmol/L组、1.0 nmol/L组、10.0 nmol/L组、100.0 nmol/L组、1 000.0 nmol/L组。ATV处理12 h后,细胞免疫荧光法、蛋白免疫印迹法(Western blot)检测各组细胞中CXCR4蛋白表达;实时定量聚合酶链反应(RT-PCR)检测各组细胞中CXCR4 mRNA表达;Transwell小室法检测细胞迁移能力。组间细胞中mRNA、蛋白表达和细胞迁移能力比较行独立样本t检验。结果细胞免疫荧光法检测结果显示,1.0 nmol/L组、10.0 nmol/L组细胞中CXCR4蛋白表达量较对照组、0.1 nmol/L组、100.0 nmol/L组、1 000.0 nmol/L组明显增高;RT-PCR、Western blot检测结果显示,10.0 nmol/L组细胞中CXCR4 mARNA、蛋白表达均较1.0 nmol/L组和对照组明显增高,差异有统计学意义(FmARNA=20.36,P=0.005;F蛋白=33.17,P=0.009);Transwell小室法检测结果显示,10.0 nmol/L组细胞迁移能力较1.0 nmol/L和对照组明显提高,差异有统计学意义(F=43.77,P=0.000)。结论较低浓度ATV可呈剂量依赖性促进体外培养的BMSC中CXCR4表达并提高其迁移能力。

ObjectiveTo investigate the effects of migration and expression from chemokine receptor 4 (chemokine receptor-4, CXCR4) of rat bone marrow mesenchymal stem cells (BMSCs) which were pretreated by atorvastatin (ATV) in vitro.MethodsIsolated, cultivated, identified the BMSCs, pretreated P4-P6 of BMSCs with different concentrations of ATV for 12 hours. The experimental group was divided into control group, 0.1 nM/L (group 0.1 nM), 1 nM/L (1 nM group), 10 nM/L (10 nM group), 100 nM/L (100 nM group), 1 000 nM/L (1 000 nM group). The mRNA and protein of CXCR4 were determined by real time-polymerase chain reaction and Western blot. Immunofluoreseence assay were used to detect the expression levels of CXCR4. The migration ability of BMSCs were measured by transwell chamber.ResultsImmunofluoreseence assay showed the protein level of CXCR4 of group 1 nM and 10 nM were significantly higher than the other group. RT-PCR and Western blot showed the protein and mRNA level of CXCR4 in 10 nM was higher than that in group 1 nM. The migration ability of group 10 nM was higher than 1 nM and control group.ConclusionsATV can be dose-dependent promote expression levels of CXCR4 of BMSCs cultivated in vitro.

关键词: 间质干细胞; 阿托伐他汀; 受体,CXCR4; 细胞,培养的

Key words: Mesenchymal stem cell; Atorvastatin; Receptors, CXCR4; Cell, cultured

引用本文: 武斌, 陈松, 张惟, 何广辉, 王健. 阿托伐他汀对体外培养的大鼠骨髓间充质干细胞CXC趋化因子受体4表达及迁移能力的影响. 中华眼底病杂志, 2018, 34(6): 575-579. doi: 10.3760/cma.j.issn.1005-1015.2018.06.010 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Megaw R, Dhillon B.Stem cell therapies in the management of diabetic retinopathy[J]. Curr Diab Rep, 2014, 14(7): 498. DOI: 10.1007/s11892-014-0498-9.
2. Kavanagh H, Mahon BP. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells[J]. Allergy, 2011, 66(4): 523-531. DOI: 10.1111/j.1398-9995.2010.02509.x.
3. Yan H, Wu M, Yuan Y, et al. Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor[J]. Biochem Biophys Res Commun, 2014, 448(2): 212-217. DOI: 10.1016/j.bbrc.2014.04.097.
4. 段红涛, 陈松.间充质干细胞在视网膜疾病应用研究进展[J]. 中国实用眼科杂志, 2015, 33 (3): 213-216. DOI: 10.3760/cma.j.issn.1006-4443.2015.03.001.Duan HT, Cheng S.Progress in the application of mesenchymal stem cells in retinal diseases[J]. Chin J Pract Ophthalmol, 2015, 33 (3): 213-216.DOI: 10.3760/cma.j.issn.1006-4443.2015.03.001.
5. Tolar J, Nauta AJ, Osborn MJ, et al. Sarcoma derived from cultured mesenchymal stem cells[J]. Stem Cells, 2007, 25(2): 371-379. DOI: 10.1634/stemcells.2005-0620.
6. Yi T, Song SU. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications[J]. Arch Pharm Res, 2012, 35(2): 213-221. DOI: 10.1007/s12272-012-0202-z.
7. Galipeau J. The mesenchymal stromal cells dilemma--does a negative phase Ⅲtrial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?[J]. Cytotherapy, 2013, 15(1): 2-8. DOI: 10.1016/j.jcyt.2012.10.002.
8. 王健, 陈松.基质细胞衍生因子-1/CXC趋化因子受体4通路在间充质干细胞治疗糖尿病视网膜病变中的作用研究[J]. 中华眼底病杂志, 2016, 32(6): 663-667. DOI: 10.3760/cma.j.issn.1005-1015.2016.06.029.Wang J, Chen S. Role of stromal cell derived factor-1/CXC chemokine receptor 4 pathway in mesenchymal stem cells therapies in the management of diabetic retinopathy[J]. Chin J Ocul Fundus Dis, 2016, 32(6): 663-667.DOI: 10.3760/cma.j.issn.1005-1015.2016.06.029.
9. 宋雷, 杨跃进, 董秋婷, 等. 阿托伐他汀主要经AMP蛋白激酶而非PI3K/Akt信号通路抑制猪骨髓间充质干细胞凋亡[J]. 中华心血管病杂志, 2011, 39(11): 1033-1038. DOI: 10.3760/cma.j.issn.0253-3758.2011.11.013.Song L, Yang YJ, Dong QT, et al. Atorvastatin protects swine bone marrow mesenchymal stem cells from apoptosis through AMPK but not PI3K/Akt pathway[J]. Chin J Cardiol, 2011, 39(11): 1033-1038. DOI: 10.3760/cma.j.issn.0253-3758.2011.11.013.
10. Zhang Y, Wittner M, Bouamar H, et al. Identification of CXCR4 as a new nitric oxide-regulated gene in human CD34+cells[J]. Stem Cells, 2007, 25(1): 211-219. DOI: 10.1634/stemcells.2006-0468.
11. Yamagishi S, Matsui T. Advanced glycation end products(AGEs), oxidative stress and diabetic retinopathy[J]. Cnit Pharm Biotechnol, 2011, 12(3): 362-368.
12. Lee JK, Park SR, Jung BK, et al. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells[J/OL]. PLoS One, 2013, 8(12): 84256[2013-12-31]. http://dx.plos.org/1al.pone.0084256.
13. Lai RC, Yeo RW, Padmanabhan J, et al. Isolation andcharacterization of exosome from human embryonic stem cellderived C-myc-immortalized mesenchymal stem cells[J]. Methods Mol Biol, 2016, 1416: 477-494.DOI: 10.1007/978-1-4939-3584-0_29.
14. Nakano M, Nagaishi K, Konari N, et al. Bone marrow. derivedmesenchymal stem ceils improve diabetes-induced cognitiveimpairment by exosome transfer into damaged neurons and astrocytes [J]. Sci Rep, 2016, 22(6): 24805.DOI: 10.1038/srep24805.
15. Boomsma RA, Geenen DL.Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis[J/OL]. PLoS One, 2012, 7 (4): 35685[2012-04-25]. https://doi.org/10.1371/journal.pone.0035685. DOI: 10.1371/journal.pone.0035685.
16. Xu X, Zhu F, Zhang M, et al.Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization[J]. Cells Tissues Organs, 2013, 197(2): 103-113. DOI: 10.1159/000342921.
17. Bolli R, Dawn B. The cornucopia of " pleiotropic” actions of statins: myogenesis as a new mechanism for statin-induced benefits[J]. Circ Res, 2009, 104(2): 144-146. DOI: 10.1161/CIRCRESAHA.108.192500.
18. Nakanishi C, Yamagishi M, Yamahara K, et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells[J]. Biochem Biophys Res Commun, 2008, 374 (1): 11-16. DOI: 10.1016/j.bbrc.2008.06.074.
19. Li N, Yang YJ, Qian HY, et al. Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4[J]. Am J Transl Res, 2015, 7(6): 1058-1070.
20. 张惟, 韩琪, 陈松, 等.辛伐他汀对糖尿病大鼠骨髓内皮祖细胞数量和功能的影响[J]. 中华眼科杂志, 2012, 48(11): 1015-1020.DOI: 10.3760/cma.j.issn.0412-4081.2012.11.013.Zhang.Zhang W, Han Q, Chen S, et al. Effect of simvastatin on the amount and function of endothelial progenitor cells from bone marrow in diabetic rats[J]. Chin J Ophthalmol, 2012, 48(11): 1015-1020. DOI: 10.3760/cma.j.issn.0412-4081.2012.11.013.